sepsis
Quercetin delivery, a strategy to pharmacologically inhibit HMGB1 release that is effective at clinically achievable concentrations, now warrants further evaluation in sepsis and other systemic inflammatory disorders.
Quercetin delivery, a strategy to pharmacologically inhibit <span class="gene" id="19265175-8-60-65">HMGB1</span> release that is effective at clinically achievable concentrations, now warrants further evaluation in <span class="disease" id="19265175-8-168-174">sepsis</span> and other systemic inflammatory disorders.